GlassScriptPhysician profile
Arjun Ramesh
NPI 1487034419
$23,744.72
in general payments reported to CMS, 2019-2025
25 companies · $6,512 in 2025
The $6,512 reported for 2025 was more than what 92% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,512 · 2020: $842 · 2021: $1,038 · 2022: $1,617 · 2023: $3,429 · 2024: $7,794 · 2025: $6,512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,877 · Food and Beverage: $7,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,876.73 |
| Food and Beverage | $7,858.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,741.16 | 2019-2025 | Proclaim, Eterna, Axium |
| Medtronic, INC. | $4,798.53 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $3,008.08 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Biotronik Nro, INC. | $2,244.95 | 2025 | Prospera |
| Nevro Corp. | $1,853.42 | 2019-2021 | |
| Globus Medical, INC. | $1,229.24 | 2025 | Senza |
| Medtronic USA, INC. | $681.69 | 2019-2020 | |
| Spr Therapeutics, INC | $224.07 | 2020-2025 | Sprint Pns System |
| Amgen INC. | $183.81 | 2019 | |
| Collegium Pharmaceutical, INC. | $107.59 | 2022-2024 | Belbuca |
| Relievant Medsystems, INC. | $82.07 | 2021-2023 | Intracept |
| Ibsa Pharma INC. | $78.03 | 2021-2023 | Tirosint, Licart |
| Si-Bone, INC. | $65.02 | 2020-2021 | |
| Captiva Spine INC | $63.10 | 2024 | Towerlox |
| Vertos Medical, INC. | $58.14 | 2022-2023 | Mild Device Kit |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $55.83 | 2023 | Optimesh Expandable Interbody Fusion System |
| Fidia Pharma USA INC. | $46.11 | 2022-2023 | Hymovis, Triluron |
| Curonix LLC | $40.77 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Scilex Pharmaceuticals INC. | $40.19 | 2021-2022 | |
| Hikma Pharmaceuticals USA | $40.13 | 2022 | |
| Saluda Medical Americas, INC. | $29.31 | 2023-2024 | Evoke Scs, Evoke |
| Redhill Biopharma INC. | $28.20 | 2020 | |
| Horizon Therapeutics Plc | $17.19 | 2021 | |
| Arteriocyte Medical Systems, INC. | $14.56 | 2021 | |
| Stimwave Technologies Incorporated | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Ramesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.